Literature DB >> 31134140

Antibody immunity and natural resistance to cryptococcosis.

N Trevijano-Contador1, L Pirofski1,2.   

Abstract

The encapsulated fungus Cryptococcus neoformans (Cn) causes cryptococcal meningitis (CM). There are ~180,000 deaths per year worldwide attributed to CM, which is the most common cause of meningitis in adults with HIV in sub-Saharan Africa. HIV infection with advanced immunodeficiency is the most important predisposing risk factor for CM, highlighting the critical role that T cell mediated immunity plays in disease prevention. Numerous studies in the past decade demonstrate that antibody immunity also plays a role in resistance to CM, although its role has taken more time to establish. In mice, B cells reduce early dissemination from lungs to brain, and naïve mouse IgM can enhance fungal containment in the lungs. In concert with these findings, human studies show that patients with CM have lower IgM memory B cell levels and/or different serological profiles than controls. In this article, we review recent data on the role that B cells and/or antibody-based immunity play in host defense against Cn and natural resistance to CM.

Entities:  

Keywords:  B-cells; Cryptococcus neoformans; IgM; adaptive response; antibodies; host immunity

Year:  2019        PMID: 31134140      PMCID: PMC6533914          DOI: 10.1007/s40475-019-00174-1

Source DB:  PubMed          Journal:  Curr Trop Med Rep


  46 in total

1.  Possible primary ecological niche of Cryptococcus neoformans.

Authors:  M S Lazera; M A Salmito Cavalcanti; A T Londero; L Trilles; M M Nishikawa; B Wanke
Journal:  Med Mycol       Date:  2000-10       Impact factor: 4.076

Review 2.  Peripheral development of B cells in mouse and man.

Authors:  Rita Carsetti; M Manuela Rosado; Hedda Wardmann
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

3.  Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.

Authors:  Krishanthi Subramaniam; Neil French; Liise-Anne Pirofski
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.

Authors:  J Abadi; L a Pirofski
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

Review 5.  Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans.

Authors:  A Casadevall; L Pirofski
Journal:  Curr Mol Med       Date:  2005-06       Impact factor: 2.222

6.  Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses.

Authors:  Marta Feldmesser; Aron Mednick; Arturo Casadevall
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth.

Authors:  M L Rodrigues; L R Travassos; K R Miranda; A J Franzen; S Rozental; W de Souza; C S Alviano; E Barreto-Bergter
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans.

Authors:  Johanna Rivera; Arturo Casadevall
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

9.  Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis.

Authors:  R Fleuridor; R H Lyles; L Pirofski
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

10.  X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea.

Authors:  Eun Kyeong Jo; Hyung Seok Kim; Min Young Lee; Motohiro Iseki; Jae Ho Lee; Chang Hwa Song; Jeong Kyu Park; Tai Ju Hwang; Hoon Kook
Journal:  J Korean Med Sci       Date:  2002-02       Impact factor: 2.153

View more
  2 in total

1.  Human IgM Inhibits the Formation of Titan-Like Cells in Cryptococcus neoformans.

Authors:  Nuria Trevijano-Contador; Kaila M Pianalto; Connie B Nichols; Oscar Zaragoza; J Andrew Alspaugh; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.

Authors:  A Elisabeth Gressler; Daniela Volke; Carolina Firacative; Christiane L Schnabel; Uwe Müller; Andor Krizsan; Bianca Schulze-Richter; Matthias Brock; Frank Brombacher; Patricia Escandón; Ralf Hoffmann; Gottfried Alber
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.